サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1388113

爪周囲炎治療市場、シェア、規模、動向、産業分析レポート：タイプ別、製品別、エンドユーザー別、地域別、セグメント別予測、2023-2032年

Paronychia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Acute Paronychia and Chronic Paronychia); By Product; By End User; By Region; Segment Forecast, 2023-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
爪周囲炎治療市場、シェア、規模、動向、産業分析レポート：タイプ別、製品別、エンドユーザー別、地域別、セグメント別予測、2023-2032年
出版日: 2023年10月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market researchの最新調査によると、世界の爪周囲炎治療市場規模は2032年までに9億3,378万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界の爪周囲炎の有病率の上昇、医療専門家と一般住民の両方における爪周囲炎に関する認知度の向上、さまざまな治療オプションの利用可能性、新しい効果的な治療オプションの導入に焦点を当てた継続的な研究開発活動と相まって、市場成長を推進する主要な顕著な要因です。さらに、安全で効果的な治療法の開発と承認を支援するいくつかの有利な規制政策が、市場への投資とイノベーションを奨励する一方で、市場成長にプラスの影響を与える可能性が高いです。

例えば、2021年5月、ジョンソン・エンド・ジョンソンのヤンセン・ファーマシューティカル・カンパニーズは、米国食品医薬品局が、主に筋骨格痛、爪周囲炎、吐き気、疲労、浮腫の患者の治療のために開発されたRYBREVANT（TM）を承認したと発表しました。

世界中のヘルスケア専門家や一般住民の間で爪周囲炎に対する認識を高めることが重視されるようになり、いくつかの政府や民間のヘルスケア機関は、爪周囲炎治療の選択肢の利用可能性についてより多くの人々に知ってもらうために、様々な教育キャンペーン、啓発プログラム、オンラインリソースを実施しており、これらの治療法の需要と採用は大きな人気と牽引力を得ています。

さらに、皮膚科を含む広範な医療専門分野での遠隔医療とデジタルヘルス技術の高まり、特に皮膚科専門医へのアクセスが限られている地域での遠隔診察、診断、患者のフォローアップケアを可能にする遠隔医療プラットフォームの急増する統合も、市場成長に影響を与える主な要因となっています。このほか、爪周囲炎のリスクを軽減するための予防策やライフスタイルの改善にますます注目が集まっており、こうした治療オプションの実施にプラスに寄与しています。

爪周囲炎治療市場レポートハイライト

2022年の市場シェアは急性爪周囲炎が最も高く、これは主に爪の不衛生や爪の外傷による爪周囲炎患者数の増加が背景にあります。

ムピロシン軟膏セグメントは2022年に最大の市場収益シェアを占めたが、これは主にさまざまな製剤で広く入手可能であることと、ヘルスケア専門家の間で高い採用率を示していることによる。

皮膚科センター部門は、世界中で皮膚科センターが増加していること、また先端技術を取り入れていることから、今後数年間で最も高い成長率が見込まれます。

北米地域は、発達したヘルスケアインフラの存在と、爪周囲炎の治療可能性に関する認知度の上昇により、2022年に最大のシェアを占めました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の爪周囲炎治療市場に関する洞察

  • 爪周囲炎治療市場- エンドユーザーのスナップショット
  • 爪周囲炎治療市場力学
    • 促進要因と機会
      • 爪周囲炎の有病率の増加
      • 医療技術の進歩
    • 抑制要因と課題
      • 認識と診断が限定的
  • PESTEL分析
  • 爪周囲炎治療市場のエンドユーザー動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の爪周囲炎治療市場、製品別

  • 主な調査結果
  • イントロダクション
  • ムピロシン軟膏
  • フシジン酸軟膏
  • ゲンタマイシン軟膏
  • ジクロキサシリン

第6章 世界の爪周囲炎治療市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 急性爪囲炎
  • 慢性爪囲炎

第7章 世界の爪周囲炎治療市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院とクリニック
  • 皮膚科センター

第8章 世界の爪周囲炎治療市場、地域別

  • 主な調査結果
  • イントロダクション
    • 爪周囲炎治療市場評価、地域別、2019-2032年
  • 爪周囲炎治療市場-北米
    • 北米：爪周囲炎治療市場、製品別、2019-2032年
    • 北米：爪周囲炎治療市場、エンドユーザー別、2019～2032年
    • 北米：爪周囲炎治療市場、タイプ別、2019-2032年
    • 爪周囲炎治療市場-米国
    • 爪周囲炎治療市場- カナダ
  • 爪周囲炎治療市場- 欧州
    • 欧州：爪周囲炎治療市場、製品別、2019～2032年
    • 欧州：爪周囲炎治療市場、エンドユーザー別、2019～2032年
    • 欧州：爪周囲炎治療市場、タイプ別、2019～2032年
    • 爪周囲炎治療市場- 英国
    • 爪周囲炎治療市場- フランス
    • 爪周囲炎治療市場- ドイツ
    • 爪周囲炎治療市場- イタリア
    • 爪周囲炎治療市場- スペイン
    • 爪周囲炎治療市場- オランダ
    • 爪周囲炎治療市場- ロシア
  • 爪周囲炎治療市場- アジア太平洋
    • アジア太平洋：爪周囲炎治療市場、製品別、2019～2032年
    • アジア太平洋：爪周囲炎治療市場、エンドユーザー別、2019～2032年
    • アジア太平洋：爪周囲炎治療市場、タイプ別、2019～2032年
    • 爪周囲炎治療市場- 中国
    • 爪周囲炎治療市場- インド
    • 爪周囲炎治療市場- マレーシア
    • 爪周囲炎治療市場- 日本
    • 爪周囲炎治療市場- インドネシア
    • 爪周囲炎治療市場- 韓国
  • 爪周囲炎治療市場-中東およびアフリカ
    • 中東およびアフリカ：爪周囲炎治療市場、製品別、2019～2032年
    • 中東およびアフリカ：爪周囲炎治療市場、エンドユーザー別、2019～2032年
    • 中東およびアフリカ：爪周囲炎治療市場、タイプ別、2019～2032年
    • 爪周囲炎治療市場- サウジアラビア
    • 爪周囲炎治療市場- アラブ首長国連邦
    • 爪周囲炎治療市場- イスラエル
    • 爪周囲炎治療市場- 南アフリカ
  • 爪周囲炎治療市場-ラテンアメリカ
    • ラテンアメリカ：爪周囲炎治療市場、製品別、2019-2032年
    • ラテンアメリカ：爪周囲炎治療市場、エンドユーザー別、2019～2032年
    • ラテンアメリカ：爪周囲炎治療市場、タイプ別、2019-2032年
    • 爪周囲炎治療市場- メキシコ
    • 爪周囲炎治療市場- ブラジル
    • 爪周囲炎治療市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Allergen Plc
  • Bayer AG
  • Eli Lilly Company
  • Fougera Pharmaceuticals Inc.
  • GlaxoSmithKline Plc
  • Glenmark Generics
  • Johnson & Johnson Services Inc.
  • Jonakayem Pharma Formulation Pvt. Ltd.
  • Merck & Co. Inc.
  • Novartis AG
  • Perrigo New York Inc.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Taro Pharmaceutical Industries
  • Teva Pharmaceutical Industries Ltd.
図表

List of Tables

  • Table 1 Global Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 3 Global Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 4 Paronychia Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 7 North America: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 13 Canada: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 16 Europe: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 19 UK: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 22 France: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 25 Germany: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 28 Italy: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 31 Spain: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 37 Russia: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 43 China: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 46 India: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 52 Japan: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 67 UAE: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 70 Israel: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Paronychia Treatment Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Paronychia Treatment Market, by Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Paronychia Treatment Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Paronychia Treatment Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Paronychia Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Paronychia Treatment Market
目次
Product Code: PM3807

The global paronychia treatment market size is expected to reach USD 933.78 million by 2032, according to a new study by Polaris market research. The report "Paronychia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Acute Paronychia and Chronic Paronychia); By Product; By End Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of paronychia worldwide and improved awareness about the paronychia among both the healthcare professionals and general population coupled with the availability of a range of treatment options and ongoing research and development activities focused on introducing new effective treatment options, are major prominent factors propelling the market growth. Additionally, several favorable regulatory policies that supports the development and approval of safe and effective treatments, while encouraging the investment and innovations in the market, is further likely to have a positive impact on market growth.

For instance, in May 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson, said that the US Food and Drug Administration, has approved the RYBREVANT™, mainly developed for the treatment of patients with musculoskeletal pain, paronychia, nausea, fatigue and edema.

With the growing emphasis on raising awareness about paronychia among healthcare professionals and the general population across the world, several government and private healthcare institutions are undertaking various educational campaigns, awareness programs, and online resources to make people more aware about the availability of the paronychia treatment options, the demand and adoption of these treatments have gained significant popularity and traction.

Moreover, the rising incorporation of telemedicine and digital health technology across wide range of medical specialties including dermatology along with the surging integration of telemedicine platforms, which enables remote consultations, diagnosis, and follow-up care for patients, especially in regions with limited access to dermatological specialists, have also been the key factor influencing the market growth. Beside this, there has been an increasing focus on preventive measures and lifestyle modifications to reduce the risk of paronychia, that positively contributes to the implementation on these treatment options.

Paronychia Treatment Market Report Highlights

Acute paronychia segment accounted for highest market share in 2022, which is mainly driven by growing number of paronychia cases because of higher penetration for poor nail hygiene and trauma to nail

Mupirocin ointment segment held the maximum market revenue share in 2022, mainly due to its widespread availability in different formulations and high adoption among healthcare professionals

Dermatology centers segment is expected to grow at highest growth rate over the coming years, owing to increasing number of dermatology centers worldwide and incorporation of advanced technologies

North America region held largest share in 2022, on account of presence of developed healthcare infrastructure and rising awareness about the treatment availability for paronychia

The global key market players include: Teva Pharmaceutical Industries, Eli Lilly Company, Fougera Pharmaceuticals, Johnson & Johnson Services, Bayer AG, Pfizer Inc., and Sandoz International

Polaris market research has segmented the paronychia treatment market report based on type, product, end user, and region:

Paronychia Treatment, Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Acute Paronychia
  • Chronic Paronychia

Paronychia Treatment, Product Outlook (Revenue - USD Million, 2023 - 2032)

  • Mupirocin Ointment
  • Fusidic Acid Ointment
  • Gentamicin Ointment
  • Dicloxacillin

Paronychia Treatment, End User Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospitals & Clinics
  • Dermatology Centers

Paronychia Treatment, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Paronychia Treatment Market Insights

  • 4.1. Paronychia Treatment Market - End User Snapshot
  • 4.2. Paronychia Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Paronychia
      • 4.2.1.2. Advancements in Medical Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Awareness and Diagnosis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Paronychia Treatment Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Paronychia Treatment Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
  • 5.3. Mupirocin Ointment
    • 5.3.1. Global Paronychia Treatment Market, by Mupirocin Ointment, by Region, 2019-2032 (USD Million)
  • 5.4. Fusidic Acid Ointment
    • 5.4.1. Global Paronychia Treatment Market, by Fusidic Acid Ointment, by Region, 2019-2032 (USD Million)
  • 5.5. Gentamicin Ointment
    • 5.5.1. Global Paronychia Treatment Market, by Gentamicin Ointment, by Region, 2019-2032 (USD Million)
  • 5.6. Dicloxacillin
    • 5.6.1. Global Paronychia Treatment Market, by Dicloxacillin, by Region, 2019-2032 (USD Million)

6. Global Paronychia Treatment Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • 6.3. Acute Paronychia
    • 6.3.1. Global Paronychia Treatment Market, by Acute Paronychia, by Region, 2019-2032 (USD Million)
  • 6.4. Chromic Paronychia
    • 6.4.1. Global Paronychia Treatment Market, by Chromic Paronychia, by Region, 2019-2032 (USD Million)

7. Global Paronychia Treatment Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Paronychia Treatment Market, by Hospitals & Clinics, By Region, 2019-2032 (USD Million)
  • 7.4. Dermatology Centers
    • 7.4.1. Global Paronychia Treatment Market, by Dermatology Centers, By Region, 2019-2032 (USD Million)

8. Global Paronychia Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Paronychia Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Paronychia Treatment Market - North America
    • 8.3.1. North America: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.3.4. Paronychia Treatment Market - U.S.
      • 8.3.4.1. U.S.: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.3.5. Paronychia Treatment Market - Canada
      • 8.3.5.1. Canada: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • 8.4. Paronychia Treatment Market - Europe
    • 8.4.1. Europe: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.4. Paronychia Treatment Market - UK
      • 8.4.4.1. UK: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.5. Paronychia Treatment Market - France
      • 8.4.5.1. France: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.6. Paronychia Treatment Market - Germany
      • 8.4.6.1. Germany: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.7. Paronychia Treatment Market - Italy
      • 8.4.7.1. Italy: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.8. Paronychia Treatment Market - Spain
      • 8.4.8.1. Spain: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.9. Paronychia Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.4.10. Paronychia Treatment Market - Russia
      • 8.4.10.1. Russia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • 8.5. Paronychia Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.4. Paronychia Treatment Market - China
      • 8.5.4.1. China: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.5. Paronychia Treatment Market - India
      • 8.5.5.1. India: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.6. Paronychia Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.7. Paronychia Treatment Market - Japan
      • 8.5.7.1. Japan: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.8. Paronychia Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.5.9. Paronychia Treatment Market - South Korea
      • 8.5.9.1. South Korea: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • 8.6. Paronychia Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.6.4. Paronychia Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.6.5. Paronychia Treatment Market - UAE
      • 8.6.5.1. UAE: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.6.6. Paronychia Treatment Market - Israel
      • 8.6.6.1. Israel: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.6.7. Paronychia Treatment Market - South Africa
      • 8.6.7.1. South Africa: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
  • 8.7. Paronychia Treatment Market - Latin America
    • 8.7.1. Latin America: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.7.4. Paronychia Treatment Market - Mexico
      • 8.7.4.1. Mexico: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.7.5. Paronychia Treatment Market - Brazil
      • 8.7.5.1. Brazil: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)
    • 8.7.6. Paronychia Treatment Market - Argentina
      • 8.7.6.1. Argentina: Paronychia Treatment Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Paronychia Treatment Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Paronychia Treatment Market, by Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Allergen Plc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Eli Lilly Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fougera Pharmaceuticals Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GlaxoSmithKline Plc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Glenmark Generics
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Johnson & Johnson Services Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Jonakayem Pharma Formulation Pvt. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck & Co. Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11.Perrigo New York Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Pfizer Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sandoz International GmbH
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Taro Pharmaceutical Industries
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Teva Pharmaceutical Industries Ltd.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development